Abstract
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Highlights
Difference not significant comparing preterm delivery (PTD) in patients starting new continuous HAART (17.2%) with pre-conception HAART (12.6%)
PTD occurred in 17/142 (12.%) women treated with nevirapine-based HAART compared with 24/102 (23.5%)
Of the 64 patients treated with a short-course of HAART (START) during pregnancy to prevent motherto-child HIV transmission 33 were eligible, if willing to delivery by pre-labour caesarean section (PLCS) to receive zidovudine monotherapy (ZDVm) according to the 2008 BHIVA guidelines1
Summary
High preterm delivery rates associated with initiation of HAART during pregnancy From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. Purpose of the study To understand the relationship between HAART and preterm delivery (PTD). Methods Analysis of prospectively collected data from all patients attending HIV antenatal services at a single UK centre 1995—2010.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
